The primary objective of the study is to assess the impact of the organizational model of the hematology center on the quality of life of patients with CML estimated through standardized tools (EORTC QLQ-30, CML24) and through the patient's opinion regarding aspects of the quality of care.
Subjects aged 18 years or older.
Subjects diagnosed with Chronic Myeloid Leukemia.
Subjects diagnosed with CML under care at the hematology outpatient clinics of the 21 REL centers.
Subjects followed at the reference hematology center for a minimum of 6 months.
Subjects who have not given consent to participate in the study.
Subjects who do not meet the inclusion criteria.